C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 1057-1060

  Strandberg, Timo E ^a   Tilvis, Reijo S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

C reactive protein; Elderly; Mortality

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

EID: 0034113993     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.1057     Document Type: Article

References (24)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
4. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733
5. Lowe GDO, Rumely A, Sweetnam PM, Yarnell JWG. D-dimer, C-reactive protein and risk of ischemic heart disease: the Speedwell study. Blood Coagul Fibrinolysis. 1999;10(suppl 1):S92-S93.
6. Koenig W, Sund M, Fröhlich M, Fischer H-G, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.
7. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
8. Harris TB, Ferruci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
9. Lindroos M, Kupari M, Heikkilä J, Tilvis RS. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
10. Rose GA. Chest pain questionnaire. Milbank Q. 1965;43:32-39.
11. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc. 1998;46:712-715.
12. Tilvis RS, Känönen M, Härkönen M. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging (Milano). 1999;11:30-34.
13. National Biological Standard Board. First international standard for human C-reactive protein established 1986, code 85/506. National Institute for Biological Standards and Controls.
14. Dixon WJ, ed. BMDP: Statistical Software. London, UK: University of California Press; 1988.
15. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061-1065.
16. Hak AE, Stehouwer CDA, Bots ML, Polderman KH, Schalkwijk CG, Westendorp ICD, Hofman A, Witteman JCM. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999;19:1986-1991.
17. Cohen Pieper, Harris TB, Rao KMK, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol Med Sci. 1997;52A:M201-M208.
18. Bauer J, Strauss S. Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berger M. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 1991;285: 111-114.
19. Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. Brain Res. 1993; 629:245-252.
20. Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging. 1994;15:771-772.
21. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-2011.
22. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E, for the CARE investigators. Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998;98:839-844.
23. Strandberg TE, Vanhanen H, Tikkanen MJ. Effect of statin treatment on C-reactive protein in coronary patients. Lancet. 1999;353:118-119.
24. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100:230-235.